Dihydronicotinamid-adenin-dinucleotid-phosphat

reduced · NADPN · NADPH · NADPH2 · Na4 salt · ent-NADPH · β-NADPH-d4 · NADPH ≥98%

Identifikatoren & physikalische Daten

CAS No.	53-57-6
Summenformel	C21H30N7O17P3
Durchschnittliche Molmasse	745,4 g/mol
SMILES	NC(=O)C1=CN([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)C=CC1
InChIKey	ACFIXJIJDZMPPO-NNYOXOHSSA-N
PubChem CID	5884
ChEMBL	CHEMBL407009
ChEBI	CHEBI:16474
EC No.	200-177-6
DTXSID	DTXSID001018921
Lokaler Name	Dihydronicotinamid-adenin-dinucleotid-phosphat

Chemische & physikalische Eigenschaften

XLogP	-6,8
Polarare Oberfläche (TPSA)	364
H-Brücken-Donoren	9
H-Brücken-Akzeptoren	22
Frei drehbare Bindungen	13
Schwere Atome	48
Formalladung	0
Komplexität	1.410
Stoffklassen	Biological Agents -> Other Biomolecules
Arzneimittel	Pharmaceuticals -> Listed in ZINC15
Physical Description	Solid
Collision Cross Section	240.5 Å² [M+Na-H]+ [CCS Type: DTMethod: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]246.7 Å² [M-H]-
Siedepunkt	1175.1±75.0 °C(Predicted)
Dichte	2.28±0.1 g/cm3(Predicted)
pKa (Säurekonstante)	1.13±0.50(Predicted)
Aggregatzustand	Solid
Farbe	White to light yellow
EPA chemische Informationen	Nicotinamide adenine dinucleotide phosphate (53-57-6)

Sicherheit & Vorschriften

Regulatorische Informationen	Adenosine 5'-(trihydrogen diphosphate), 2'-(dihydrogen phosphate), P'â5'-ester with 1,4-dihydro-1-.beta.-D-ribofuranosyl-3-pyridinecarboxamide: Does not have an individual approval but may be used under an appropriate group standard
Gefahrenübersicht	See NADP.
TSCA-Inventar-Status	TSCA listed

Anwendungen & Verwendung

Verwenden

One of the biologically active forms of nicotinic acid. Differs from NAD by an additional phosphate group at the 2position of the adenosine moiety. Serves as a coenzyme of hydrogenases and dehydrogenases. Present in living cells primarily in the r